✦ LIBER ✦

138 ADJUVANT MULTIMODALITY TREATMENT IN PATIENTS WITH HIGH RISK PROSTATE CANCER FOLLOWING RADICAL PROSTATECTOMY: RESULTS OF A PROSPECTIVE CLINICAL PHASE-II TRIAL

✍ Scribed by A. Heidenreich; C. Ohlmann; D. Pfister; D. Thüer; U.H. Engelmann

Book ID: 119617470
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 317 KB
Volume: 6
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(07)60137-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

766 FEASIBILITY OF RADICAL PROSTATECTOMY

766 FEASIBILITY OF RADICAL PROSTATECTOMY FOLLOWING NEOADJUVANT IXABEPILONE FOR HIGH-RISK PROSTATE CANCER: A PHASE II CLINICAL TRIAL

✍ Maddox, Michael; Layton, Jodi; Taber, Angela; Mega, Anthony; Renzulli, Joseph 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 212 KB

Phase II Trial of Neoadjuvant Nab-Paclit

Phase II Trial of Neoadjuvant Nab-Paclitaxel in High Risk Patients With Prostate Cancer Undergoing Radical Prostatectomy

✍ Shepard, D.R.; Dreicer, R.; Garcia, J.; Elson, P.; Magi-Galluzzi, C.; Raghavan, 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 607 KB

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib

Long-term follow-up of a neoadjuvant che

Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer

✍ Tomaso Prayer-Galetti; Emilio Sacco; Francesco Pagano; Marina Gardiman; Antonio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Multimodal treatment for high-risk prost

Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial

✍ Guttilla, Andrea; Bortolus, Roberto; Giannarini, Gianluca; Ghadjar, Pirus; Zatto 📂 Article 📅 2014 🏛 BioMed Central 🌐 English ⚖ 249 KB

Outcome Predictors of Radical Prostatect

Outcome Predictors of Radical Prostatectomy Followed by Adjuvant Androgen Deprivation in Patients with Clinical High Risk Prostate Cancer and pT3 Surgical Margin Positive Disease

✍ Spahn, Martin; Briganti, Alberto; Capitanio, Umberto; Kneitz, Burkhard; Gontero, 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 423 KB